Picture of Gelteq logo

GELS Gelteq Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Annual income statement for Gelteq, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

2020
June 30th
2021
June 30th
Period Length:12 M12 M
Source:PROSPECTUSPROSPECTUS
Standards:
IFRS
IFRS
Status:FinalFinal
Total Revenue00
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses0.530.807
Operating Profit-0.53-0.807
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes-0.53-0.809
Provision for Income Taxes
Net Income After Taxes-0.376-0.649
Net Income Before Extraordinary Items
Net Income-0.376-0.649
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income-0.376-0.649
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.039-0.068
Dividends per Share